The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Serena Williams has been a health extremist all her life. She's now partnered with Lingo, a continuous glucose monitor that ...

(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...

With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.

Starting Jan. 1, 2026, Pennsylvania will limit GLP‑1 weight‑loss drugs under Medicaid — threatening access for thousands of ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

The coexistence of type 2 diabetes and obesity represents a major global health challenge that significantly increases cardiovascular and metabolic risk.

Drugs like semaglutide, liraglutide, and tirzepatide—known as GLP-1 receptor agonists—are commonly used to help manage type 2 ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...